Amata A. Soriano

San Giovanni Rotondo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Study of POLR3A variants in a family trio suggests mutation-specific pathogenetic mechanisms: insights from integrative OMIC approaches.

Study of POLR3A variants in a family trio suggests mutation-specific pathogenetic mechanisms: insights from integrative OMIC approaches.

Journal: Cell communication and signaling : CCS

Published: October 13, 2025

Different states of stemness of glioblastoma stem cells sustain glioblastoma subtypes indicating novel clinical biomarkers and high-efficacy customized therapies.

Different states of stemness of glioblastoma stem cells sustain glioblastoma subtypes indicating novel clinical biomarkers and high-efficacy customized therapies.

Journal: Journal of experimental & clinical cancer research : CR

Published: June 07, 2023

Corrigendum: Deepening the understanding of CNVs on chromosome 15q11-13 by using hiPSCs: An overview.

Corrigendum: Deepening the understanding of CNVs on chromosome 15q11-13 by using hiPSCs: An overview.

Journal: Frontiers in cell and developmental biology

Published: January 10, 2023

Deepening the understanding of CNVs on chromosome 15q11-13 by using hiPSCs: An overview.

Deepening the understanding of CNVs on chromosome 15q11-13 by using hiPSCs: An overview.

Journal: Frontiers in cell and developmental biology

Published: November 25, 2022

Growth factor independence underpins a paroxysmal, aggressive Wnt5aHigh/EphA2Low phenotype in glioblastoma stem cells, conducive to experimental combinatorial therapy.

Growth factor independence underpins a paroxysmal, aggressive Wnt5aHigh/EphA2Low phenotype in glioblastoma stem cells, conducive to experimental combinatorial therapy.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 22, 2021

PAX8, an Emerging Player in Ovarian Cancer.

PAX8, an Emerging Player in Ovarian Cancer.

Journal: Advances in experimental medicine and biology

Published: August 02, 2021

BRAFV600E mutation impinges on gut microbial markers defining novel biomarkers for serrated colorectal cancer effective therapies.

BRAFV600E mutation impinges on gut microbial markers defining novel biomarkers for serrated colorectal cancer effective therapies.

Journal: Journal of experimental & clinical cancer research : CR

Published: October 12, 2020

Long Non-Coding RNA HAND2-AS1 Acts as a Tumor Suppressor in High-Grade Serous Ovarian Carcinoma.

Long Non-Coding RNA HAND2-AS1 Acts as a Tumor Suppressor in High-Grade Serous Ovarian Carcinoma.

Journal: International journal of molecular sciences

Published: May 05, 2020

Long Non-Coding RNA MAGI2-AS3 is a New Player with a Tumor Suppressive Role in High Grade Serous Ovarian Carcinoma.

Long Non-Coding RNA MAGI2-AS3 is a New Player with a Tumor Suppressive Role in High Grade Serous Ovarian Carcinoma.

Journal: Cancers

Published: November 19, 2019

PAX8 expression in high-grade serous ovarian cancer positively regulates attachment to ECM via Integrin β3.

PAX8 expression in high-grade serous ovarian cancer positively regulates attachment to ECM via Integrin β3.

Journal: Cancer cell international

Published: April 02, 2019

In Vivo Biofilm Formation, Gram-Negative Infections and TAS2R38 Polymorphisms in CRSw NP Patients.

In Vivo Biofilm Formation, Gram-Negative Infections and TAS2R38 Polymorphisms in CRSw NP Patients.

Journal: The Laryngoscope

Published: November 08, 2017

Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma.

Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma.

Journal: Oncotarget

Published: March 24, 2016

Showing 1-12 of 16

Last Updated: 09/26/2026